Exhibit 107

EX-FILING FEES

Calculation of Filing Fee Tables

Form S-8

(Form Type)

RedHill Biopharma Ltd.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered Securities and Carry Forward Securities

Security
Type

Security
Class
Title

Fee
Calculation
or Carry
Forward
Rule

Amount
Registered (2)

Proposed
Maximum
Offering
Price Per
Unit

Maximum
Aggregate
Offering
Price (3)

Fee
Rate

Amount of
Registration
Fee

Fees to Be Paid

Equity

Ordinary Shares, par value NIS 0.01 per share (1)

457(h)

2,000,000,000

$0.0027

5,400,000

0.0001531

826.74

Total Offering Amounts

Total Fees Previously Paid

Total Fee Offsets

Net Fee Due

826.74

(1)

Deposited as American Depositary Shares (“ADSs”), evidenced by American Depositary Receipts, issuable upon deposit of the ordinary shares registered hereby, par value NIS 0.01 per share (“Ordinary Shares”), of Redhill Biopharma Ltd. (the “Company”) are registered on a separate registration statement on Form F-6 (File No. 333-268713). Each ADS represents ten thousand (10,000) Ordinary Shares.

(2)

Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall also cover any additional Ordinary Shares that become issuable under the Redhill Biopharma Ltd. Amended and Restated Award Plan (2010), as amended by reason of any stock dividend, stock split, or other similar transaction.

(3)	Estimated solely for purposes of calculating the registration fee pursuant to Rules 457(c) and 457(h) under the Securities Act and based on the average of the high and low prices of the Company’s ADSs reported on the NASDAQ Capital Market on March 20, 2025.